Characterizing Oseltamivir Use among Community-Dwelling Patients Diagnosed with Influenza Virus Infection, 2023-2025
This study of U.S. outpatient influenza cases from 2023–2025 reveals that oseltamivir initiation rates were suboptimal even among high-risk individuals, with treatment completion being particularly low among young children and overall only reaching 42% of those who started the medication.